This Week at FDA: CMS inflation rebates, FTC steps into Amneal patent dispute, and a new GAO report

This Week at FDAThis Week at FDADiagnostics/IVDsDigital health/SaMD/AIGenericsMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited States